These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7562128)

  • 1. Thrombolytic therapy: just do it.
    Fendrick AM
    J Gen Intern Med; 1995 Jun; 10(6):351-2. PubMed ID: 7562128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Innovations in thrombolytic therapy in heart and coronary diseases].
    Bode C
    Hamostaseologie; 2007 Dec; 27(5):317. PubMed ID: 18060239
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
    Naylor CD; Bronskill S; Goel V
    Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thrombolytic therapy].
    Matsuda T
    Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctive antithrombotic and thrombolytic therapy for coronary-artery occlusion.
    Gold HK
    N Engl J Med; 1990 Nov; 323(21):1483-5. PubMed ID: 2233922
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of patterns of drug therapy in Hungary and in developed Western countries for acute coronary syndromes].
    Keltai M
    Orv Hetil; 2000 Jun; 141(26):1449-53. PubMed ID: 10936933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis in cardiopulmonary disease.
    Chest; 1990 Apr; 97(4 Suppl):115S-181S. PubMed ID: 2323266
    [No Abstract]   [Full Text] [Related]  

  • 8. Canadian Consensus Conference on Coronary Thrombolysis--1994 update.
    Cairns J; Armstrong P; Belenkie I; Hirsh J; Johnstone D; Knudtson M; Lemieux M; Massel D; Naylor D; Roy L
    Can J Cardiol; 1994 Jun; 10(5):517-21. PubMed ID: 8012879
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic therapy in acute coronary syndromes.
    Sabatine MS; Jang IK
    Acta Cardiol; 1999 Feb; 54(1):3-29. PubMed ID: 10214473
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antithrombotic drugs in the acute coronary syndrome].
    Jareño Chaumel A; Cercas Sánchez A
    Rev Clin Esp; 1996 Dec; 196(4 Monografico):26-38. PubMed ID: 9139329
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary thrombolysis.
    Cairns JA; Fuster V; Gore J; Kennedy JW
    Chest; 1995 Oct; 108(4 Suppl):401S-423S. PubMed ID: 7555192
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Hull RD; Weg JG
    Chest; 1995 Oct; 108(4 Suppl):335S-351S. PubMed ID: 7555187
    [No Abstract]   [Full Text] [Related]  

  • 13. [The optimization of the results with the use of thrombolytic therapy in acute myocardial infarct (I)].
    Cerveró Martí A
    Med Clin (Barc); 1993 May; 100(17):668-74. PubMed ID: 8497174
    [No Abstract]   [Full Text] [Related]  

  • 14. Using efficacy, safety, and cost data to support a formulary decision regarding thrombolytic therapy.
    Leonard MC; Shermock KM
    Semin Vasc Surg; 2001 Jun; 14(2):150-5. PubMed ID: 11400091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GP-IIb/IIIa antagonists expand the anti thrombotic therapy of acute coronary syndromes. Satellite symposium during the 21st Congress of the European Society of Cardiology. Barcelona, August 1999].
    Dtsch Med Wochenschr; 1999 Dec; 124(48 Suppl):1-4. PubMed ID: 10631845
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protocols for the prevention and treatment of thromboembolic disease (III). Antithrombotic therapy in coronary disease. The Editorial Committee on Protocols (1)].
    Med Clin (Barc); 1994 Sep; 103(9):344-7. PubMed ID: 7967896
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombolytic therapy in acute coronary syndrome--Part I].
    Barbash G
    Harefuah; 1989 Feb; 116(3):152-8. PubMed ID: 2653984
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of acute coronary syndromes of the "non-ST elevation" type with enoxaparin: the TIMI 11B study. Thrombolysis in Myocardial Infarct].
    Galli M
    Ital Heart J Suppl; 2000 Apr; 1(4):575-6. PubMed ID: 10832148
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiplatelet effects of fibrinolytic agents: a potential contributor to the hemostatic defect after thrombolysis.
    Kamat SG; Schafer AI
    Coron Artery Dis; 1995 Dec; 6(12):930-5. PubMed ID: 8723014
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct versus indirect thrombin inhibition in percutaneous coronary intervention.
    Marmur JD
    J Invasive Cardiol; 2002 Apr; 14 Suppl B():8B-18B. PubMed ID: 11967386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.